论文部分内容阅读
目的探讨并比较经尿道等离子前列腺剜除术(PKEP)与经尿道等离子前列腺电切术(PKRP)治疗良性前列腺增生(BPH)的安全性和有效性。方法回顾性分析95例BPH患者接受PKEP及PKRP两种手术方式,就2组患者的手术时间、出血量、前列腺腺体切除量、术后留置尿管时间、术后住院天数、手术并发症等进行比较;对2组患者术前、术后3个月国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(PVR)、最大尿流率(Qmax)进行比较。结果 49例行PKEP,46例行PKRP,2组患者术前情况比较差异无统计学意义。2组患者手术后的QOL、PVR、IPSS、Qmax与各自术前比较均改善,其差异有统计学意义(P<0.05),但上述指标在2组间比较差异无统计学意义(P>0.05)。PKEP组在手术的出血量、术后留置尿管时间及术后住院时间明显少于PKRP组(P<0.05);PKEP组前列腺腺体切除量也高于PKRP组(P<0.05)。结论 PKEP与PKRP在治疗BPH中,二者的临床疗效相当,但PKEP在术后留置尿管时间和住院时间较PKRP短、出血量较少,是治疗BPH的安全有效方法。
Objective To explore and compare the safety and efficacy of transurethral plasmaphotonotomy (PKEP) and transurethral plasmakinetic prostatectomy (PKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods A retrospective analysis of 95 cases of BPH patients receiving PKEP and PKRP two surgical methods, the two groups of patients operating time, blood loss, prostate gland resection, postoperative catheterization, postoperative hospital stay, complications such as surgery (IPSS), quality of life score (QOL), residual urine volume (PVR) and maximum blood flow rate (Qmax) were compared between the two groups before and 3 months after surgery. Results 49 cases of PKEP, 46 cases of PKRP, two groups of patients with preoperative difference was not statistically significant. The postoperative QOL, PVR, IPSS and Qmax were improved in both groups (P <0.05), but there was no significant difference between the two groups (P> 0.05 ). The amount of bleeding, postoperative catheterization and postoperative hospital stay in PKEP group were significantly less than those in PKRP group (P <0.05). The amount of prostate gland resection in PKEP group was also higher than PKRP group (P <0.05). Conclusions The clinical efficacy of PKEP and PKRP in the treatment of BPH is similar. However, PKEP has shorter postoperative catheterization and hospitalization time than PKRP and less bleeding, which is a safe and effective method for the treatment of BPH.